Rightsmile, Inc. (RIGH)

[MrTempleton]

RIGH PR GREAT ARTICLE HOT OFF THE PRESS Bud Genius Receives Funding Commitment from Angel Investor
8:37a ET August 21, 2014 (Business Wire) Print
Funding to establish Bud Genius' (OTC:RIGH) new subsidiary, called Genius Biotech Corporation, was received last week, and an angel investment group has committed to putting in initial capital for the new project, which will more than double the scope of the company's business.

Regarding the group of angel investors who have committed to putting in capital, Stanz said, "We think it was a great deal for the investors who put money into the project, and also will be a great deal for us. They were very demanding about wanting full reporting, audits, and internal financial controls. All of our shareholders will benefit from this."

The funding commitment will pay for certain company expenses to be announced after paperwork has been signed.

About Bud Genius An early leader in an industry that many are speculating will grow, Bud Genius is one of the first established analytical cannabis laboratories in the United States. Bud Genius was launched to bring vendors together with doctors, patients, and dispensaries that require certified products held to demanding standards. Bud Genius has a vision to expand across the US and abroad serving as the beacon of quality for medical cannabis and adult-use marijuana through the formation of regional laboratories. Certification, data collection, and online reports are the measure by which the company gains.

For more information please visit: http://www.BudGenius.com